JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 1R01AI150305-01
Understanding Down Syndrome as an Interferonopathy
National Institutes of Health
Grant: 3R01AI145988-02S1
Pre-clinical assessment of JAK inhibitors to ameliorate cytokine storms in Down syndrome
Fields of Study
Keywords
Sustainable Development Goals